Trial Profile
Effect of combination of tretinoin and arsenic trioxide in patients with newly diagnosed acute promyelocytic leukemia
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Mar 2015
Price :
$35
*
At a glance
- Drugs Arsenic trioxide (Primary) ; Tretinoin (Primary)
- Indications Acute promyelocytic leukaemia
- Focus Therapeutic Use
- 17 Mar 2015 New trial record